Filing Flows

Filing Flows › Utah Medical Products (UTMD) › Q3 2025

Utah Medical Products (UTMD) Q3 2025 earnings results (third quarter 2025)

10-Q filed Nov 14, 2025

Utah Medical Products (UTMD) reported revenue of $9.8M for the third quarter 2025 (Q3 2025), -2% from a year earlier and -1% from the quarter before. Operating margin was 26.6%, net earnings $2.6M (26.8% of revenue).

Revenue$9.8M
Year over year-2%
Quarter over quarter-1%
Operating margin26.6%
Net earnings$2.6M

Utah Medical Products, Q3 2025: revenue $9.8M (-2% year over year), operating margin 26.6%, net earnings $2.6M, operating cash flow $3.9M. The chart follows the revenue to costs, profit and cash.

Q3 2025AmountQ/QY/Y
Revenue$9.8M-1%-2%
Gross profit$5.6M+0.2%-3%
Operating profit$2.6M-18%-22%
Net earnings$2.6M-14%-26%
Operating cash flow$3.9M+35%+0.6%
Free cash flow$3.9M+36%+2%

What changed

Revenue was $9.8M in Q3 2025, down 2% year over year and down 1% from the previous quarter. Gynecology/Electrosurgery/Urology was the largest line at 50% of revenue.

Gross margin was 57.1%, down 0.9 points from a year earlier. Operating profit was $2.6M, a 26.6% margin (down 6.8 points year over year). Operating expenses grew 22% against a revenue fall of 2%. The fastest-growing cost line was SG&A (+24%). Net earnings were $2.6M, down 26% year over year. The effective tax rate was 20.5%. Non-operating items added $698K, 21% of pre-tax earnings, so the bottom line overstates operating performance.

Operating cash flow was $3.9M (up 1% year over year), 147% of net earnings. Non-cash charges added back $754K of depreciation and amortization and $94K of share-based compensation. Working capital and other items added $399K. Capital expenditures of $27K left free cash flow of $3.9M.

Questions

What was Utah Medical Products' revenue in the third quarter 2025?

Utah Medical Products (UTMD) reported revenue of $9.8M for the third quarter 2025 (Q3 2025), -2% from a year earlier and -1% from the quarter before.

Was Utah Medical Products profitable in the third quarter 2025?

Operating profit was $2.6M (26.6% of revenue) and net earnings $2.6M.

Open the interactive Sankey →

Source: Utah Medical Products 10-Q on SEC EDGAR.